Skip to main content
Log in

B-Lymphozyten als Effektoren und Regulatoren beim systemischen Lupus erythematosus

B-lymphocytes as effectors and regulators in systemic lupus erythematosus

  • Neues aus der Forschung
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Arbuckle MR, Mcclain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533

    Article  CAS  PubMed  Google Scholar 

  2. Barr TA, Shen P, Brown S et al (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209:1001–1010

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Blair PA, Noreña LY, Flores-Borja F et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129–140

    Article  CAS  PubMed  Google Scholar 

  4. Kalampokis I, Yoshizaki A, Tedder TF (2013) IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 15(Suppl 1):1–12

    Article  Google Scholar 

  5. Mumtaz IM, Hoyer BF, Panne D et al (2012) Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. J Autoimmun 39:180–188

    Article  CAS  PubMed  Google Scholar 

  6. Neubert K, Meister S, Moser K et al (2008) The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14:748–755

    Article  CAS  PubMed  Google Scholar 

  7. Neves P, Lampropoulou V, Calderon-Gomez E et al (2010) Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33:777–790

    Article  CAS  PubMed  Google Scholar 

  8. Pawar RD, Ramanjaneyulu A, Kulkarni OP et al (2007) Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 18:1721–1731

    Article  CAS  PubMed  Google Scholar 

  9. Teichmann LL, Schenten D, Medzhitov R et al (2013) Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38:528–540

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Wahren-Herlenius M, Dorner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382:819–831

    Article  CAS  PubMed  Google Scholar 

  11. Yoshizaki A, Miyagaki T, Dilillo DJ et al (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491:264–268

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Interessenkonflikt

T.H. Winkler gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T.H. Winkler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winkler, T. B-Lymphozyten als Effektoren und Regulatoren beim systemischen Lupus erythematosus. Z. Rheumatol. 73, 360–362 (2014). https://doi.org/10.1007/s00393-013-1295-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-013-1295-6

Navigation